REFERENCES
- Lyketsos C G, Steinberg M, Tschanz J T, Norton M C, Steffans D C, Breitner J CS. Mental and behavioural disturbances in dementia: findings from the Cache County Study on Memory in Aging. Am J Psychiatry 2000; 157: 708–714
- Margallo-Lana M, Swann A, O'Brien J T, et al. Prevalence and pharmacological management of behavioral and psychological symptoms amongst dementia sufferers living in care environments. Int J Geriatr Psychiatry 2001; 16: 39–44
- Howard R J, Juszczak E, Ballard C G, et al. Donepezil for the treatment of agitation in Alzheimer's disease. N Engl J Med 2007; 357: 1382–1392
- Zempsky W T, Bean-Lijewski J, Kauffman R E, et al. Needle-free powder lidocaine delivery system provides rapid effective analgesia for venipuncture or cannulation pain in children: randomized, double-blind comparison of venipuncture and venous cannulation pain after fast-onset needle-free powder lidocaine or placebo treatment trial. Pediatrics 2008; 121: 979–987
- Candy M, Jones L, Williams R, Tookman A, King M. Psychostimulants for depression. Cochrane Database Syst Rev 2008; 16(2), CD006722
- Akl E A, Barba M, Rohilla S, et al. Anticoagulation for the long term treatment of venous thromboembolism in patients with cancer. Cochrane Database Syst Rev 2008, (2):CD006650
- American Pain Foundation. Pain Facts & Figures, Available at www.painfoundation.org/page.asp?file=Newsroom/PainFacts.htm Accessed May 13, 2008
- National Center for Health Statistics. Health, United States, 2007, With Chartbook on Trends in the Health of Americans. Centers for Disease Control and Prevention, US Department of Health and Human Services, Hyattsville, MD 2007, Available at www.cdc.gov/nchs/data/hus/hus07.pdf#summary Accessed May 13, 2008
- Lynch M E, Campbell F, Clark A J, et al. A systematic review of the effect of waiting for treatment for chronic pain. Pain 2008; 136: 97–116
- Rzany B, Mockenhaupt M, Baur S, Schröder Stocker W U, Mueller J, et al. Epidemiology of erythema exsudativum multiforme majus (EEMM), Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) in Germany (1990–1992). Structure and results of a population based registry. J Clin Epidemiol 1996; 49: 769–773
- Halevy S, Ghislain P D, Mockenhaupt M, et al. Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel. J Am Acad Dermatol 2008; 58: 25–32
- Mockenhaupt M, Viboud C, Dunant A, Naldi L, Halevy S, Bouwes Bavinck J N, Sidoroff A, Schneck J, Roujeau J C, Flahault A. Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study. J Invest Dermatol 2008; 128: 35–44